Sfoglia per RIVISTA
ANNALS OF HEMATOLOGY
Collezione AOU San Luigi di Orbassano
Items : 8
Anti-CD20 maintenance strategies to face the challenge of COVID-19 pandemic in follicular lymphoma: results from the R-FolSTOP multicentre Italian study. in Annals of hematology / Ann Hematol. 2025 Mar;104(3):1655-1667. doi: 10.1007/s00277-025-06295-0. Epub 2025 Mar 12.
2025
AO Cuneo
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara
Massaia M; Castellino C; Galimberti S; Rattotti S; Annibali O; Conconi A; Margiotta-Casaluci G; Farina L; Meli E; Anastasia A; Bozzoli V; Mecacci B; Bigliardi S; Merli M; Cocito F; Marchesi F; Fanelli F; Perrone T; Clerico M; Nicoli P; Vanazzi A; Boccomini C; Comba L; Bertolotti L; Castellino A;
Antiviral prophylaxis to prevent herpes simplex virus (HSV) and varicella zoster virus (VZV) reactivation in adult patients with newly diagnosed acute leukemia: results of a survey submitted to Italian centers belonging to SEIFEM (Sorveglianza Epidemiologica Infezioni nelle Emopatie) group. in Annals of hematology / Ann Hematol. 2024 Oct;103(10):4329-4332. doi: 10.1007/s00277-024-05927-1. Epub 2024 Aug 8.
2024
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
Pagano L; Busca A; Luppi M; Vignetti M; Candoni A; Santoni A; Pezone S; Perruccio K; Cattaneo C; Fracchiolla NS; Dargenio M; Zannier ME; Cerchione C; Audisio E; Melillo L; Delia M; Buquicchio C; Prezioso L; Guolo F; Fiorentini A; Bonanni M; Criscuolo M; Cavalieri E; Pasciolla C; Itri F; Del Principe MI; Marchesi F; Cordella S; Forghieri F; et alii...
Efficacy and safety of nilotinib as frontline treatment in elderly (>?65 years) chronic myeloid leukemia patients outside clinical trials. in Annals of hematology / Ann Hematol. 2023 Jun;102(6):1375-1382. doi: 10.1007/s00277-023-05159-9. Epub 2023 Apr 20.
2023
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
Castagnetti F; Iurlo A; Sica S; Iovine M; Dragani M; Pregno P; Palmieri R; Albano F; Sorà F; Galimberti S; Esposito MR; Bocchia M; Sica A; Martino B; Tiribelli M; Annunziata M; Latagliata R; Gugliotta G; Luciano L; Rosti G; Breccia M;
Clone wars: co-occurrence of IDH2 R140Q and R172K in myelodysplastic syndromes. in Annals of hematology / Ann Hematol. 2020 Apr;99(4):891-893. doi: 10.1007/s00277-020-03913-x. Epub 2020 Feb 4.
2020
AOU San Luigi di Orbassano
Rosso V; Petiti J; Dragani M; Andreani G; Croce E; Lo Iacono M; Saglio G; Fava C; Cilloni D;
Outcome of very elderly chronic myeloid leukaemia patients treated with imatinib frontline. in Annals of hematology / Ann Hematol. 2019 Oct;98(10):2329-2338. doi: 10.1007/s00277-019-03767-y. Epub 2019 Aug 7.
2019
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
Calistri E; Bocchia M; Orlandi E; Galimberti S; D'Addosio A; Storti S; Sorà F; Celesti F; Giglio G; Atelda R; Mauro E; Isidori A; Pregno P; RussoRossi A; Russo S; Cedrone M; Crisà E; Gugliotta G; Montefusco E; Falzetti F; Gozzini A; Mansueto G; Bucelli C; Iurlo A; Fava C; Bonifacio M; Binotto G; Tiribelli M; Annunziata M; et alii...
Pleural effusion and molecular response in dasatinib-treated chronic myeloid leukemia patients in a real-life Italian multicenter series. in Annals of hematology / Ann Hematol. 2018 Jan;97(1):95-100. doi: 10.1007/s00277-017-3144-1. Epub 2017 Oct 2.
2018
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
Baccarani M; Specchia G; Cortelezzi A; Saglio G; Rosti G; Pane F; Bocchia M; Sica S; Breccia M; Luciano L; Martino B; Rege-Cambrin G; Stagno F; Castagnetti F; Gugliotta G; Tiribelli M; Gozzini A; Pungolino E; Bucelli C; Binotto G; Cattaneo D; Fava C; Orlandi EM; Sorà F; Ferrero D; Pregno P; Latagliata R; Annunziata M; Bonifacio M; et alii...
Evaluation of cardiovascular ischemic event rates in dasatinib-treated patients using standardized incidence ratios. in Annals of hematology / Ann Hematol. 2017 Aug;96(8):1303-1313. doi: 10.1007/s00277-017-3012-z. Epub 2017 May 22.
2017
AOU San Luigi di Orbassano
Saglio G; le Coutre P; Cortes J; Mayer J; Rowlings P; Mahon FX; Kroog G; Gooden K; Subar M; Shah NP;
The choice of first-line chronic myelogenous leukemia treatment. in Annals of hematology / Ann Hematol. 2015 Apr;94 Suppl 2(Suppl 2):S123-31. doi: 10.1007/s00277-015-2321-3. Epub 2015 Mar 27.
2015
AOU San Luigi di Orbassano
Fava C; Rege-Cambrin G; Saglio G;